ArticleTherapeutic advances in chronic disease2024

The impact of elexacaftor/tezacaftor/ivacaftor on cystic fibrosis health-related quality of life and decision-making about daily treatment regimens: a mixed methods exploratory study.

Melissa Basile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.